You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金域醫學:獲先進製造產業投資基金二期定增8.5億元,股價一度大漲7%
格隆匯 04-16 11:51

4月15日晚間金域醫學(603882.SH)披露2020年度非公開發行預案顯示,擬募集資金總額不超10億元,扣除發行費用後將用於償還銀行貸款和補充流動資金。

image.png

來源:金域醫學2020年非公開發行預案

其中,擬非公開發行的股票數量合計不超過2073.4萬股(含2,073.40萬股),發行數量不超過此次非公開發行前公司總股本的30%非公開發行股票每股48.23元

同時,本次發行對象主要2名特定對象,包括外部戰略投資者國投招商管理的先進製造產業投資基金二期及公司控股股東暨實際控制人樑耀銘。其中,先進製造產業投資基金二期認購1762.39萬股,為8.5億元樑耀銘認購311.01萬股,為1.5億元。

image.png來源:金域醫學 2020年非公開發行預案

據資料顯示,先進製造產業投資基金二期是2019年11月有成立,募集規模500億元。該基金重點投向軌道交通裝備、工業機器人、新能源汽車等領域,支持了寧德時代、上海聯影、中集來福士等一批先進製造業企業。

受此次募集資金影響,金域醫學今日開盤雖小幅下跌,但在臨近10點時一度拉昇後震盪回落,臨近午間收盤小幅拉昇。截至午間收盤,股價上升5.06%,報收69.34元,成交額4.52億元,換手率2.38%,總市值317.5億元。

image.png

來源:Wind

據金域醫學的財報顯示,公司2016年、2017年、2018年及2019年1-9月的營業收入分別為32.22億元、37.92億元、45.25億元和39.20億元,分別同比增長34.83%、17.70%、19.35%和18.17%。

image.png

金域醫學2019年第三季度報告 來源:Wind

受行業當前發展趨勢和競爭格局的影響,公司近年來不斷擴大的業務規模,未來幾年公司生產經營、市場開拓、研發投入等活動中需要大量的營運資金

值得關注的是,目前公司應收賬款16.82億元存貨1.85億元,合計佔流動資產總值的66%,對公司日常的運營資金需求形成了一定壓力。通過這次發行募集資金可在一定程度上解決公司因業務規模擴張而產生的營運資金需求,緩解快速發展的資金壓力。

image.png

來源:Wind

此外,據公司財報顯示,金域醫學的資產負債率也是相當高的。其中,2016-2018年的資產負債率分別是57.51%,47.48%,50.58%,2019年截至9月的資產負債率49.04%。同時,該公司2016-2019年的流動比率和速動比率均在1以上。

image.png

來源:金域醫學2020年非公開發行預案

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account